Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ciputra Development Tbk (CTRA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Ciputra Development TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Ciputra Development Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ciputra Development Tbk trades at Rp590 (market cap 11.03T, 2M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 33.3K 24h volume). The key difference: Ciputra Development Tbk is far larger — about 67× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (2M versus 33.3K). Which is the better fit depends on your goals.

CTRAOBAT
Market Cap
11.03T164.65B
Volume
2M33.3K
Lot
19.97K333
Turnover
1.19B8.05M
Average Price
594.57241.64
Value
1.19B8.05M
Indicative Equilibrium Price
595238
Indicative Equilibrium Volume
114.6K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTRA
View details
OBAT
View details

About Ciputra Development Tbk

PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.

Read more on CTRA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT